Brazil invests R$42m in surveillance systems
This article was originally published in Clinica
Executive Summary
Brazil's healthcare surveillance laboratories are to get almost R$42m (US$23.7m) this year to upgrade their facilities and to address new operational demands. The network of 27 central public health laboratories (Lacens) and the national healthcare quality controls institute (INCQS) are to receive, on the one hand, more than R$16.7m, to be shared among the laboratories for infrastructural and equipment improvements; on the other, R$25.1m will go to funding the network's operational costs in 2008.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.